Enter your information to understand your fibrinogen levels.

The History of Fibrinogen

The scientific study of blood clotting traces back to Estonian physiologist Alexander Schmidt, who in the 1870s proposed that a specific plasma protein converted into the fibrous mesh of a blood clot through the action of what he termed a "fibrin ferment," laying the essential conceptual groundwork for modern coagulation science. Schmidt's protein, later named fibrinogen, became more precisely characterized biochemically during the 1940s, as wartime blood transfusion research urgently demanded a clearer, more practical understanding of exactly how plasma proteins interacted during the clotting process. Swiss researcher Alfred Clauss then made the field's most lasting clinical contribution in 1957, developing a simple, standardized functional test still known today as the Clauss method, which remains the most widely used way to measure fibrinogen in laboratories worldwide.

What Fibrinogen Actually Is

Fibrinogen, also formally known as coagulation Factor I, is a soluble protein manufactured by the liver and released continuously into the bloodstream, where it circulates quietly until it's needed for the critical work of forming a blood clot. When an injury occurs, the enzyme thrombin cleaves fibrinogen into fibrin, which then polymerizes into the tough, web-like mesh that traps blood cells and platelets together, forming the physical structure of a stable clot at the wound site. Like ferritin, fibrinogen also behaves as an acute-phase reactant, meaning its levels rise noticeably during infection, inflammation, tissue injury, or pregnancy, so an elevated result doesn't always indicate a primary clotting disorder on its own.

How Fibrinogen Is Measured

The Clauss method, developed by Alfred Clauss in 1957, remains the clinical gold standard for measuring fibrinogen, working by adding a strong, standardized concentration of thrombin to diluted patient plasma and precisely timing how quickly a visible clot forms, since that clotting time correlates directly and predictably with fibrinogen concentration. Modern automated coagulation analyzers now perform this same functional clotting assay electronically, using optical or mechanical clot-detection sensors to time the reaction with far greater speed and precision than any manual laboratory technique from decades past ever could achieve. An alternative, less commonly used method calculates fibrinogen indirectly from the broader prothrombin time test, though most laboratories today strongly and consistently prefer the more accurate, purpose-built Clauss assay for routine everyday clinical testing.

Scientists Behind the Science

Alexander Schmidt's nineteenth-century fibrin ferment theory represents the true intellectual origin of modern coagulation science, correctly identifying decades before anyone could isolate the actual proteins involved that blood clotting depended on a specific, identifiable chemical conversion process occurring within the plasma itself. Alfred Clauss then closed the loop between that early theoretical insight and genuine everyday clinical usefulness, publishing his now-eponymous functional assay in 1957 in a form so practical and reliable that it remains, remarkably, the dominant testing method used in hospital laboratories nearly seventy years later. Together, their combined work bridged more than eighty years of steady coagulation research, transforming what was once an abstract physiological theory into one of the most routinely ordered coagulation tests in all of modern clinical medicine today.